BioLife Solutions Inc Cash Flow Conversion Efficiency
BioLife Solutions Inc cash flow conversion efficiency. Based on the latest financial reports, BioLife Solutions Inc (BLFS) has a cash flow conversion efficiency ratio of 0.015x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($6.35 Million) by net assets ($420.00 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of BioLife Solutions Inc (1989–2025)
Cash flow conversion efficiency of BioLife Solutions Inc from 1989 to 2025. This chart illustrates how BioLife Solutions Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest BioLife Solutions Inc stock price today for real-time trading data and today's change.
BioLife Solutions Inc Cash Flow Conversion Ratio Explained
BioLife Solutions Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
BioLife Solutions Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioLife Solutions Inc ranked by their cash flow conversion efficiency. Also see BLFS stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Resolute Mining Ltd
AU:RSG
|
0.174x |
|
Costamare Inc
NYSE:CMRE
|
0.044x |
|
YY Inc Class A
NASDAQ:YY
|
0.007x |
|
Alony Hetz Properties and Investments Ltd
TA:ALHE
|
0.022x |
|
Aarti Industries Limited
NSE:AARTIIND
|
0.094x |
|
Tecnoglass Inc
NYSE:TGLS
|
0.006x |
|
Nanjing Vazyme Biotech Co Ltd
SHG:688105
|
0.021x |
|
Azad Engineering Limited
NSE:AZAD
|
-0.050x |
Annual Cash Flow Conversion Efficiency for BioLife Solutions Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of BioLife Solutions Inc from 1989 to 2025. Review BioLife Solutions Inc free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $371.89 Million | $20.11 Million | 0.054x | +123.84% |
| 2024-12-31 | $348.91 Million | $8.43 Million | 0.024x | +165.28% |
| 2023-12-31 | $337.66 Million | $-12.50 Million | -0.037x | -58.79% |
| 2022-12-31 | $364.19 Million | $-8.49 Million | -0.023x | -130.42% |
| 2021-12-31 | $478.05 Million | $-4.84 Million | -0.010x | -131.87% |
| 2020-12-31 | $205.25 Million | $6.51 Million | 0.032x | +14.22% |
| 2019-12-31 | $43.65 Million | $1.21 Million | 0.028x | -82.68% |
| 2018-12-31 | $14.63 Million | $2.35 Million | 0.160x | +167.68% |
| 2017-12-31 | $10.09 Million | $605.00K | 0.060x | +104.39% |
| 2016-12-31 | $3.17 Million | $-4.33 Million | -1.367x | -170.91% |
| 2015-12-31 | $9.86 Million | $-4.97 Million | -0.504x | -122.32% |
| 2014-12-31 | $13.94 Million | $-3.16 Million | -0.227x | -1962.55% |
| 2013-12-31 | $-13.27 Million | $146.01K | -0.011x | +83.93% |
| 2012-12-31 | $-12.49 Million | $854.93K | -0.068x | -177.33% |
| 2011-12-31 | $-11.18 Million | $-989.92K | 0.089x | -32.50% |
| 2010-12-31 | $-9.55 Million | $-1.25 Million | 0.131x | -57.46% |
| 2009-12-31 | $-7.83 Million | $-2.41 Million | 0.308x | -24.55% |
| 2008-12-31 | $-5.17 Million | $-2.11 Million | 0.409x | -62.74% |
| 2007-12-31 | $-2.47 Million | $-2.71 Million | 1.097x | +127.74% |
| 2006-12-31 | $180.09K | $-712.20K | -3.955x | +73.60% |
| 2005-12-31 | $38.48K | $-576.33K | -14.977x | -1882.23% |
| 2004-12-31 | $612.96K | $515.10K | 0.840x | +233.41% |
| 2003-12-31 | $1.36 Million | $-854.23K | -0.630x | -113.04% |
| 2002-12-31 | $-554.25K | $-2.68 Million | 4.831x | +156.81% |
| 2001-12-31 | $310.77K | $-2.64 Million | -8.504x | -964.52% |
| 2000-12-31 | $3.63 Million | $-2.90 Million | -0.799x | -145.54% |
| 1999-12-31 | $818.40K | $-266.26K | -0.325x | -1699.60% |
| 1998-12-31 | $1.43 Million | $29.12K | 0.020x | +103.35% |
| 1997-12-31 | $2.46 Million | $-1.49 Million | -0.608x | -17.07% |
| 1996-12-31 | $3.99 Million | $-2.07 Million | -0.519x | -34.00% |
| 1995-12-31 | $3.98 Million | $-1.54 Million | -0.387x | 0.00% |
| 1994-12-31 | $3.98 Million | $-1.54 Million | -0.387x | +21.05% |
| 1993-12-31 | $5.30 Million | $-2.60 Million | -0.491x | +67.30% |
| 1992-12-31 | $5.60 Million | $-8.40 Million | -1.500x | -311.63% |
| 1991-12-31 | $11.80 Million | $-4.30 Million | -0.364x | +19.83% |
| 1990-12-31 | $5.50 Million | $-2.50 Million | -0.455x | -15.38% |
| 1989-12-31 | $3.30 Million | $-1.30 Million | -0.394x | -- |
About BioLife Solutions Inc
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, inc… Read more